Combination therapy with PD-1/PD-L1 blockade: An overview of ongoing clinical trials

Johnson, CB; Win, SY

Johnson, CB (reprint author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10065 USA.; Win, SY (reprint author), Medstar Harbor Hosp, Dept Internal Med, 3001 S Hanover St, Baltimore, MD 21225 USA.

ONCOIMMUNOLOGY, 2018; 7 (4):

Abstract

Monoclonal antibodies (mAbs) that block the programmed death 1 (PD-1) or programmed death-ligand 1 (PD-L1) receptors are the most clinically advanced ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索